Publications by authors named "Hanna Tilly"
Acta Neuropathol
July 2012
Article Synopsis
- Pediatric high-grade glioma (pHGG) has a poor prognosis, with a median survival of just 15 months after diagnosis, and research is shifting towards anti-angiogenic treatments.
- A study of 150 pHGG cases revealed that the vascular marker CD105 is strongly linked to worse outcomes, and 13 genes related to vascularity were identified through gene expression analysis.
- The findings suggest that targeting angiogenesis, particularly through CD105, could be an effective therapeutic approach for improving pHGG treatment.
